| Code | CSB-MP004939HU |
| Abbreviation | Recombinant Human CD46 protein, partial (Active) |
| MSDS | |
| Size | $9.9 |
| Promotion | |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
CD46 functions as a critical complement regulatory protein that protects host cells from autologous complement attack, making it a key target in cancer immune evasion research. This recombinant human CD46 construct (residues 35–328) carries a C-terminal hFc1 tag and demonstrates robust functional activity, with an EC50 of 0.83–1.05 ng/ml in binding ELISA against anti-CD46 monoclonal antibody, supporting its use as a positive control in complement ELISA and as a reliable reagent for inhibitor screening targeting complement pathways. The protein's mammalian expression ensures native-like glycosylation critical for complement regulatory function, while endotoxin levels below 1.0 EU/μg and purity exceeding 90% by SDS-PAGE satisfy the stringent criteria required for hemolytic assays, opsonization studies, and mechanistic investigations of tumor immune evasion where background inflammatory signals would confound results.
Applications : Enzymatic activity in vitro
Review: I used the CSB-MP004939HU protein with the antibody (CSB-RA908548A0HU) for an ELISA experiment, and the EC50 was measured to be 0.8000-1.380 ng/ml. The results showed that the protein has good binding activity, which met my expectations and could be used for subsequent experiments.
By Anonymous